USP - Pages 5

Iothalamic Acid (200 mg)

Neomycin A (2.5 mg)

Polyethylene Glycol 200 (1 g)

(R)-N-Methyllaudanosine Iodide (25 mg) ((R)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-2-ium, iodide)

Ioversol (200 mg)

Neomycin B (150 mg)

Polyethylene Glycol 30 Dipolyhydroxystearate 5 (200 mg)

Terbutaline Sulfate (125 mg)

Ioversol Related Compound B (50 mg) (N,N'-Bis(2,3-dihydroxypropyl)-5-{[N-(2-hydroxyethyl)amino]-2-oxoethoxy}-2,4,6-triiodoisophthalamide)

3-Desmethyl Ivabradine Hydrochloride (25 mg) (1,3,4,5-tetrahydro-3-[3-[[[(7S)-3-hydroxy-4-methoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]methylamino]propyl]-7,8-dimethoxy-2H-3-benzazepin-2-one, hydrochloride)

Neomycin Sulfate (200 mg)

Polyethylene Glycol 300 (1 g)

Neomycin Sulfate System Suitability Mixture (100 mg)

Ioxaglic Acid (100 mg)

Polyethylene Glycol 3000 (1 g)